The broad prospects of artificial intelligence (AI) have led many pharmaceutical companies to incorporate it into their strategic focus. Especially considering the current high R&D investment and long R&D cycle, even a slight improvement to the status quo is sufficient to prove that AI is actually helpful in drug development. Similarly, the increasingly important post-marketing patient support and rational drug use tracking will further promote the application of AI in the medical industry. At the same time, as the technology itself continues to evolve, AI companies are also continuing to improve their products to meet the different needs of pharmaceutical customers. Driven by the above factors, it can be foreseen that in the next ten years, AI technology will flourish in the field of biological sciences (especially drug discovery).
With automation becoming increasingly popular in the field of machine learning, one may wonder if the role of humans in machine learning will become non-essential at some point. When building a machine learning model, it's important to remember that the model must produce meaningful and interpretable results in real-life situations. This is where the human experience comes in. A human (qualified data science professional) has to examine the results produced by algorithms and computers to ensure that the results are consistent with real-world situations before recommending a model for deployment. With automation in machine learning, humans are still indispensable to make the connection between data, algorithms, and the real world.
The incorporation of AI into LIMS will equip laboratories with enhanced capabilities, enabling better data retrieval and laboratory diagnostics. FREMONT, CA: The emergence of the laboratory information management system (LIMS) has transformed the pharmaceutical industry, enabling organizations to process numerous lab samples and streamline the laboratory workflow. It has bolstered the capabilities of laboratories with robust decision support and decision making. The integration of artificial intelligence (AI) with LIMS will enable organizations to resolve many of the challenges in the industry. A vast amount of data is gathered from the multiple tasks performed on a daily basis in clinical laboratories. The data has to be stored and recorded in an orderly manner to track useful information.
The COVID-19 pandemic has increased the focus on the use of artificial intelligence (AI) across the life sciences organization, from R&D to manufacturing, supply chain, and commercial functions. During the pandemic, company leadership and management realized that they could run many aspects of their business remotely and with digital solutions. This experience has transformed mindsets; leaders are more likely to lean into a future that lies in digital investments, data, and AI because of this experience. At present, the life sciences industry has only begun to scratch the surface of AI's potential, primarily applying it to automate existing processes. By melding AI with rigorous medical and scientific knowledge, companies can do even more to leverage this technology to transform processes and achieve a competitive edge. AI has the potential to identify and validate genetic targets for drug development, design novel compounds, expedite drug development, make supply chains smarter and more responsive, and help launch and market products. We will highlight a number of these use cases in this report.
MIT Lincoln Laboratory has established a new research and development division, the Biotechnology and Human Systems Division. The division will address emerging threats to both national security and humanity. Research and development will encompass advanced technologies and systems for improving chemical and biological defense, human health and performance, and global resilience to climate change, conflict, and disasters. "We strongly believe that research and development in biology, biomedical systems, biological defense, and human systems is a critically important part of national and global security. The new division will focus on improving human conditions on many fronts," says Eric Evans, Lincoln Laboratory director.
NIR Calibration-Model Services Spectroscopy and Chemometrics News Weekly 46, 2020 NIRS NIR Spectroscopy MachineLearning Spectrometer Spectrometric Analytical Chemistry foodindustry Analysis Lab Laboratories Laboratory Software IoT Sensors QA QC Testing Quality LINK Get the Spectroscopy and Chemometrics News Weekly in real time on Twitter @ CalibModel and follow us. Near-Infrared Spectroscopy (NIRS) "Near infrared absorption spectroscopy for the quantification of unsulfated alcohol in sodium lauryl ether sulfate" LINK "Estimation of Organic Carbon in Anthropogenic Soil by VIS-NIR Spectroscopy: Effect of Variable Selection" LINK "Near infrared spectroscopy (NIRS) based high-throughput online assay for key cell wall features that determine sugarcane bagasse digestibility") LINK "Authentication of barley-finished beef using visible and near infrared spectroscopy (Vis-NIRS) and different discrimination approaches" LINK "Energetic Distribution of States in Irradiated Low-Density ...
The field of healthcare and medicine and specially the digital healthcare will get a great boost with the advancement and wide scale use of Quantum Computing and Artificial Intelligence. In fact, these technologies have already started transforming different areas of Healthcare and Medicine in a big way. Before even quantum computers were there, scientists at the University of Virginia School of Medicine long back anticipated the potential of quantum computers to better understand genetics and different diseases. The envision been realized and a team at the University's center for quantum computing & biology is now harnessing the power of quantum computing to gain better insights into genetic diseases with the help of machine learning algorithms. Researchers expecting that these efforts will benefit not only health care and medicine but also many other streams of science and technology.
As the pandemic reaches new heights, with nearly 12 million cases and 260,000 deaths recorded in the U.S. to date, a glimmer of hope is on the horizon. Moderna and pharmaceutical giant Pfizer, which are developing vaccines to fight the virus, have released preliminary data suggesting their vaccines are around 95% effective. Manufacturing and distribution is expected to ramp up as soon as the companies seek and receive approval from the U.S. Food and Drug Administration. Representatives from Moderna and Pfizer say the first doses could be available as early as December. But even if the majority of Americans agree to vaccination, the pandemic won't come to a sudden end.
From helping in optimising the yield of therapeutics to training staff for setting up large-scale manufacturing sites, cutting-edge technologies such as artificial intelligence (AI) and virtual reality (VR) can be used to fast track COVID-19 vaccine development worldwide, experts say. The search for a COVID-19 vaccine has expanded worldwide, with thousands of researchers collaborating at hundreds of laboratories to fight the virus that has infected 56 million people and claimed over 1.34 million lives so far. Recently, a panel of experts noted at the Berlin Science Week, a ten-day science festival, that AI and other technologies like machine learning (ML) can make sense of the mountains of data from several experiments by discovering patterns that a human brain might fail to spot. As vaccine candidates advance to the final phases of testing in humans, experts said AI would be vital for analysing clinical and immunological data rapidly. Rene Faber, from the pharmaceutical company Sartorius headquartered in Germany, said there is a need to utilise these "handy innovations."
Artificial Intelligence (AI) is already underway. Perhaps, not the way you may have been led to think. Though AI has been a recurring topic since the 1950s, it is only now that the field started gaining traction due to the advancement in technology and algorithms. Most companies are excited to join the new fray of the AI trend. With modern AI, deep learning techniques, and natural language processing (NLP), organizations are ready to embark on the AI journey.